J&J | JNJ - PE Price to Earnings



J&J reported 19.02 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Abbott 16.63 0.73 Jun/2025
Amgen 12.51 28.7 Jun/2025
AstraZeneca 20.04 12.31 Jun/2025
Baxter International 21.56 95.08 Jun/2025
Bayer 6.61 1.6 Jun/2025
Becton, Dickinson and Co. 22.44 16.12 Jun/2025
Biogen 12.41 0.17 Jun/2025
Boston Scientific 47.02 33.68 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
CONMED 13.67 0.54 Jun/2025
Cooper Companies 34.15 5.3 Jul/2025
Dexcom 65.63 17.98 Jun/2025
Edwards Lifesciences 30.42 0.55 Jun/2025
Eli Lilly 37 7.55 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Globus Medical 19.42 78.18 Jun/2025
Hologic 27.38 10.48 Jun/2025
Insulet 62.75 17.32 Jun/2025
Integra LifeSciences 63.02 0 Jun/2025
Intuitive Surgical 76.08 1.06 Jun/2025
J&J 19.02 9.62 Jun/2025
Medtronic 21.54 5.77 Jul/2025
Merck 8.58 4.74 Jun/2025
Merit Medical Systems 45.82 2.66 Jun/2025
Novartis 15.89 3.03 Jun/2025
Pfizer 9.12 8.86 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Roche Holding 19.32 1.87 Jun/2024
Sanofi 16.47 6.85 Jun/2025
Stryker 53.46 22.06 Jun/2025
Tandem Diabetes Care 681.05 189.32 Mar/2022
Teva Pharmaceutical Industries 9.72 15.14 Jun/2025
Vertex Pharmaceuticals 27.81 3.5 Jun/2025
Zimmer Biomet Holdings 17.06 3.59 Jun/2025
Zoetis 25.94 2.65 Jun/2025